Novartis AG (FRA:NOT)

Market Cap	196.24B
Revenue (ttm)	46.99B
Net Income (ttm)	11.63B
Shares Out	n/a
EPS (ttm)	5.83
PE Ratio	16.88
Forward PE	13.59
Dividend	3.50 (3.48%)
Ex-Dividend Date	Mar 11, 2025

Volume	670
Average Volume	921
Open	101.72
Previous Close	102.50
Day's Range	101.06 - 103.00
52-Week Range	94.56 - 106.80
Beta	n/a
RSI	50.67
Earnings Date	Jul 17, 2025

About Accolade

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Re...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NOT

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.